EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide

NCT00132522 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer
Colorectal Cancer
Carcinoma, Non-small-cell Lung
Prostate Cancer

Interventions

DRUG: EMD 273066

Sponsor

EMD Serono